NM_014232.3:c.*1590T>A
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014232.3(VAMP2):c.*1590T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: not found (cov: 27) 
 Exomes 𝑓:  0.0   (  0   hom.  ) 
 Failed GnomAD Quality Control 
Consequence
 VAMP2
NM_014232.3 3_prime_UTR
NM_014232.3 3_prime_UTR
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  1.06  
Publications
24 publications found 
Genes affected
 VAMP2  (HGNC:12643):  (vesicle associated membrane protein 2) The protein encoded by this gene is a member of the vesicle-associated membrane protein (VAMP)/synaptobrevin family. Synaptobrevins/VAMPs, syntaxins, and the 25-kD synaptosomal-associated protein SNAP25 are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane. This gene is thought to participate in neurotransmitter release at a step between docking and fusion. The protein forms a stable complex with syntaxin, synaptosomal-associated protein, 25 kD, and synaptotagmin. It also forms a distinct complex with synaptophysin. It is a likely candidate gene for familial infantile myasthenia (FIMG) because of its map location and because it encodes a synaptic vesicle protein of the type that has been implicated in the pathogenesis of FIMG. [provided by RefSeq, Jul 2008] 
VAMP2 Gene-Disease associations (from GenCC):
- neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movementsInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38). 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
27
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF:  0.00  AC: 0AN: 42Hom.:  0  Cov.: 0 AF XY:  0.00  AC XY: 0AN XY: 36 
GnomAD4 exome 
Data not reliable, filtered out with message: AC0;AS_VQSR
 AF: 
AC: 
0
AN: 
42
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
0
AN XY: 
36
African (AFR) 
AC: 
0
AN: 
0
American (AMR) 
AC: 
0
AN: 
0
Ashkenazi Jewish (ASJ) 
AC: 
0
AN: 
0
East Asian (EAS) 
AC: 
0
AN: 
0
South Asian (SAS) 
AC: 
0
AN: 
0
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
34
Middle Eastern (MID) 
AC: 
0
AN: 
0
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
8
Other (OTH) 
AC: 
0
AN: 
0
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
27
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.